4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · IEX Real-Time Price · USD

14.40

-0.74 (-4.89%)

At close: Jul 19, 2024, 4:00 PM

14.98

+0.58 (4.03%)

Pre-market: Jul 22, 2024, 9:00 AM EDT

4D Molecular Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	745	866	719	705	988
Market Cap Growth	177.60%	20.40%	2.03%	-28.62%	-
Enterprise Value	233	593	522	474	711
PE Ratio	-	-8.59	-6.69	-9.89	-17.43
PS Ratio	36.40	41.80	229.93	39.09	72.58
PB Ratio	1.24	2.81	3.11	2.21	3.85
P/FCF Ratio	-19.96	-11.03	-7.32	-9.01	-19.03
P/OCF Ratio	-20.60	-11.43	-8.30	-10.20	-19.41
EV/Sales Ratio	11.38	28.60	166.83	26.27	52.25
EV/EBITDA Ratio	-10.89	-6.23	-5.04	-6.94	-12.87
EV/EBIT Ratio	-10.27	-5.88	-4.86	-6.64	-12.54
EV/FCF Ratio	-13.52	-7.54	-5.31	-6.06	-13.70
Debt / Equity Ratio	0.02	0.05	0.07	0.05	-
Debt / EBITDA Ratio	-0.14	-0.15	-0.16	-0.24	-
Debt / FCF Ratio	-0.18	-0.19	-0.16	-0.21	-
Quick Ratio	32.06	15.21	13.58	15.17	16.62
Current Ratio	32.65	15.65	14.02	15.69	16.88
Asset Turnover	0.05	0.06	0.01	0.06	0.08
Return on Equity (ROE)	-26.70%	-34.10%	-40.90%	-27.80%	-61.80%
Return on Assets (ROA)	-24.80%	-31.10%	-36.80%	-25.50%	-32.70%
Return on Capital (ROIC)	-19.67%	-35.00%	-44.46%	-21.26%	-22.10%
Earnings Yield	-14.04%	-11.64%	-14.94%	-10.11%	-5.74%
FCF Yield	-10.67%	-9.07%	-13.65%	-11.10%	-5.25%
Buyback Yield / Dilution	-50.57%	-20.95%	-16.66%	-331.23%	-25.05%
Total Shareholder Return	-50.57%	-20.95%	-16.66%	-331.23%	-25.05%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).